Leadership

Leadership Team Comprises Expertise Necessary to Develop Products & Company

cm-new

Christopher Marshall PhD, President & CEO

Founded three biotechs, is an inventor and former strategy consultant.

Dirk 3-15

Dirk Pleimes, MD, CMO

Founded four biotechs and worked in clinical development in large pharma. Expert in respiratory-inflammatory disease.

Mark 3-15

Mark Yondola, PhD, CSO

Established Calder’s bioprocess technology. Expert in vaccine design, protein chemistry and virology.

Susan Stella

Susan Stella, MBA, Interim COO

Expert strategist with emerging tech & life science companies as well as investors.

Scientific Advisory Board

team-buckland

Barry Buckland, PhD

Merck Vaccines, VP Manufacturing for 16 years. Manufactured a large number of approved vaccine products.

Visit BiologicB

florian-new-blue

Florian Schödel, MD

Merck Vaccines, VP Clinical Research for 8 years. Directed clinical studies for licensure of multiple approved vaccines.

Visit Philimmune

team-mclellan

Jason S. McLellan, PhD

Univ. of Texas. Pre-eminent in vaccine design. Most Covid-19 vaccines programs based on Jason’s 2P-design.

Visit McLellan Lab | Visit AAAS

team-hoffman

Alexander Hoffmann, PhD

UCLA. Pre-eminent in the field of innate immunity (adjuvants); Director, Instit. for Quant. & Computational Biosciences.

Visit UCLA

 

Key Personnel

team-4-blue

Devarshi Brahmbhatt, MS

Expert in downstream process development.

team-1-blue

Sonal Gidwani, MS

Expert in crosslinking chemistry and controls; analytical development.

Experts-In-Residence

team-bertuccioli

Claudio Bertuccioli, PhD

Advising on financing strategies. Biotech VC for 15 years.

Heidi

Heidi Agostini, PhD

Consulting on govt. funding strategies. Obtained & executed $200M-$7B BARDA/DoD/NIH contracts.

James

James E. Hough, JD

Consulting on communications and strategy; partner at Morrison & Foerster LLP for 25+ years